Pharmacological options for the treatment of chronic migraine pain

被引：3
|
作者：
Urits, Ivan [1 ]
Gress, Kyle [2 ]
Charipova, Karina [2 ]
Zamarripa, Alec M. [3 ]
Patel, Parth M. [3 ]
Lassiter, Grace [2 ]
Jung, Jai Won [2 ]
Kaye, Alan D. [4 ]
Viswanath, Omar [3 ,4 ,5 ,6 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA
[2] Georgetown Univ, Sch Med, Washington, DC USA
[3] Univ Arizona, Dept Anesthesiol, Coll Med Phoenix, Phoenix, AZ USA
[4] Louisiana State Univ Hlth Shreveport, Dept Anesthesiol, Shreveport, LA USA
[5] Creighton Univ, Sch Med, Dept Anesthesiol, Omaha, NE USA
[6] Valley Pain Consultants Envision Phys Serv, Phoenix, AZ USA
来源：
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY | 2020年 / 34卷 / 03期
关键词：
migraine; preventive therapy; chronic pain; pharmacology; therapeutics; TOXIN TYPE-A; QUALITY STANDARDS SUBCOMMITTEE; LONG-TERM SAFETY; DOUBLE-BLIND; PREVENTIVE TREATMENT; PROPHYLACTIC TREATMENT; ANTINOCICEPTIVE ACTION; CENTRAL SENSITIZATION; ANTIEPILEPTIC DRUGS; ENERGY-METABOLISM;
D O I：
10.1016/j.bpa.2020.08.002
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Migraine is a debilitating neurological condition with symptoms typically consisting of unilateral and pulsating headache, sensitivity to sensory stimuli, nausea, and vomiting. The World Health Organization (WHO) reports that migraine is the third most prevalent medical disorder and second most disabling neurological condition in the world. There are several options for preventive migraine treatments that include, but are not limited to, anticonvulsants, antidepressants, beta blockers, calcium channel blockers, botulinum toxins, NSAIDs, riboflavin, and magnesium. Patients may also benefit from adjunct nonpharmacological options in the comprehensive prevention of migraines, such as cognitive behavior therapy, relaxation therapies, biofeedback, lifestyle guidance, and education. Preventative therapies are an essential component of the overall approach to the pharmacological treatment of migraine. Comparative studies of newer therapies are needed to help patients receive the best treatment option for chronic migraine pain. (C) 2020 Published by Elsevier Ltd.
引用
收藏
页码：383 / 407
页数：25
相关论文
共 50 条
  • [1] Migraine pathogenesis and state of pharmacological treatment options
    Till Sprenger
    Peter J Goadsby
    BMC Medicine, 7
  • [2] Migraine pathogenesis and state of pharmacological treatment options
    Sprenger, Till
    Goadsby, Peter J.
    BMC MEDICINE, 2009, 7
  • [3] Update on the Pharmacological Treatment of Chronic Migraine
    Sun-Edelstein, Christina
    Rapoport, Alan M.
    CURRENT PAIN AND HEADACHE REPORTS, 2016, 20 (01) : 1 - 8
  • [4] Update on the Pharmacological Treatment of Chronic Migraine
    Christina Sun-Edelstein
    Alan M. Rapoport
    Current Pain and Headache Reports, 2016, 20
  • [5] Pharmacological treatment of chronic pain
    Serpell, Mick
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2005, 6 (02): : 39 - 42
  • [6] Non-Pharmacological Treatment for Chronic Migraine
    Han, Xun
    Yu, Shengyuan
    CURRENT PAIN AND HEADACHE REPORTS, 2023, : 663 - 672
  • [7] Non-Pharmacological Treatment for Chronic Migraine
    Han, Xun
    Yu, Shengyuan
    CURRENT PAIN AND HEADACHE REPORTS, 2023,
  • [8] Non-Pharmacological Treatment for Chronic Migraine
    Xun Han
    Shengyuan Yu
    Current Pain and Headache Reports, 2023, 27 (11) : 663 - 672
  • [9] Pharmacological treatment options for acute and chronic depression
    Kanba, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 26 - 27
  • [10] New pharmacological treatment options for chronic constipation
    Corsetti, Maura
    Tack, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 927 - 941
12345